We are a biotechnology company dedicated to developing next-generation therapeutics to improve the lives of patients with severe and life-altering brain diseases. Bright Minds’ broad portfolio of new chemical entities (NCEs) are positioned to treat a variety of pain indications, seizures, and neuropsychiatric disorders.
The immense burden of mental health disorders is on the rise today all throughout the world. This is pertaining to the fact that mental health ailments like depression, bipolar mood, and even schizophrenia already exist among ten of the major reasons...Read more
The team working at Bright Minds is dedicated to developing extremely innovative therapies for addressing the most relevant and unmet medical requirements. In this manner, it has led to the paradigm transformation in the whole of the mental health sp...Read more
We have agonists that activate this receptor as well, but it is still in the pipeline. After approval from the National Institute Of Health, the psychoactive compound created by us will serve a wide range of brain health disorders associated with the...Read more
Do you feel weighed down due to prolonged use of medicine for chronic pain or a neurological disease? Millions of people worldwide are prescribed opioid medicines, which have many side effects, including addiction. At Bright Minds Biosciences, we present...Read more
Bright Minds Biosciences has a strong translational science foundation to support our drug development. Our data driven decision process allows us to de-risk our compounds to maximize the chance of success in clinical trials. We create next generation...Read more
Several researchers have suggested it is important for each human being to be involved in mental stimulation activities to generate new brain cells and communicate well with the nerve cells available in the nervous system. Mental Stimulation assists people...Read more